ProteinRS

There is 1 paper on ProteinRS in aging research: 1 observational study in people.

Biomarker

1 paper studies it2 findings

1 new paper in 30 daysSee all 1 papers on ProteinRS

“A 60-protein ProteinRS improved discrimination beyond clinical factors (area under the curve (AUC) 0.664 vs 0.647; P = 0.024).”
Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolismMolecular & cellular proteomics : MCP2026doi:10.1016/j.mcpro.2026.101692
  • Humans1

Effects

1

Venous thromboembolism risk discrimination

upin humans1

1 study
  1. ProteinRS is linked with better venous thromboembolism risk discrimination in humans (compared with clinical factors) (AUC 0.664 vs 0.647; P = 0.024).

    “A 60-protein ProteinRS improved discrimination beyond clinical factors (area under the curve (AUC) 0.664 vs 0.647; P = 0.024).”

    Humanscompared with clinical factorsn = 44,138

    Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolism

    Molecular & cellular proteomics : MCP

Associations

1

Incident venous thromboembolism

upin humans1HR 1.49

1 study
  1. ProteinRS is associated with incident venous thromboembolism in humans (above the 80th percentile versus the 20–80th percentile) (49% higher hazard; HR 1.49, 95% CI 1.17–1.90).

    “Participants above the 80th percentile of ProteinRS had a 49% higher hazard of VTE”

    Humansabove the 80th percentile versus the 20–80th percentile

    Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolism

    Molecular & cellular proteomics : MCP

More on Incident venous thromboembolism

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months